Cite Filings / MGX
Feed Companies Filings Check
Sign in
Cite Filings

Pages

  • Feed
  • Companies
  • Filings
  • Check a claim

Account

  • Sign in
  • Create an account
Support (opens in new tab)

CIK 0001785279

  • Emerging growth company

Metagenomi Therapeutics, Inc.

Sign in to watch
Ticker
MGX
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Entity type
Operating
EIN
813909017
Phone
+1 510-871-4880
Business address
5959 HORTON STREET, 7TH FLOOR, EMERYVILLE, CA, 94608
Former names
Metagenomi, Inc., Metagenomi Technologies, LLC
Filings Financials Insiders Search text
All 157 Financials 37 Shareholder Meetings 2 Executive Compensation 30 Insider Trading 73 Beneficial Ownership Interest 5 Business Combinations 25 Public Offerings 18 Mutual Funds and ETFs 2 Others 24
›
Filed in
  1. No filings match these filters. Clear filters
  2. SCHEDULE 13G Stake Statement of Beneficial Ownership 2026-09-10
  3. DEF 14A Proxy Proxy Statement 2026-04-27
  4. DEF 14A Proxy Proxy Statement 2025-04-28
  5. SC 13G Stake Amended Statement of Ownership 2024-11-06
  6. SC 13G Stake Amended Statement of Ownership 2024-05-10

Page 1 of 1 · 5 filings

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…